http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892754-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 |
filingDate | 2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104892754-B |
titleOfInvention | The human single chain variable fragments antibody 2F-scFv of anti-botulinum toxin type B enzymatic activity and its application |
abstract | The present invention provides the human single chain variable fragments antibody 2F-scFv of anti-botulinum toxin type B enzymatic activity, it is to utilize artificial synthesized recombinant protein BontB, and the substrate GFP-HIS6-SNAP25(62 of the human single chain variable fragments antibody of the anti-botulinum toxin type B enzymatic activity of screening)-VAMP(57)-C, it is screened in the anti-botulinum toxin type B enzymatic activity antibody library of humanization, affinity costant is (1.146 ± 0.525) × 10 6 L/mol, to produce, anti-botulinum toxin type B special efficacy gives treatment to drug and quickly detection botulinum toxin type B is laid a good foundation. |
priorityDate | 2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 671.